Johannes Grillari

Johannes Grillari, CSOJohannes Grillari, co-founder and scientific advisor, has more than 15 years of experience as a group leader in cellular and molecular aging research. Since 2006 he is associate professor at the Department of Biotechnology, University of Natural Resources and Life Sciences Vienna, Austria (BOKU). He accomplished his PhD degree between 1996 and 1999 on senescence of endothelial cells and worked as a visiting scientist at the University of Dundee, Scotland, UK. He has authored and co-authored more than 96 scientific articles and several book chapters, 10 patents, and was invited as speaker more than 80 times to international meetings. In addition, he is co-founder and scientific advisor of TAmiRNA GmbH (founded 2012), co-founder of Phoenestra GmbH (2015) and also co-founder of Remute Bio GmbH (2016).




Regina Grillari

Regina Grillari, CTORegina Grillari, CTO and co-founder, is associate professor for cellular biology, since 2008 leading a group focused on cellular immortalization and cell line development at the Department of Biotechnology, at BOKU. She achieved her PhD in 2000 on immortalization of human cells and recombinant protein expression and was appointed to receive the Prof. Anton Kurir habilitation award in 2009. In 2012 she received the “Phoenix Award” for successful academic entrepreneurship from the Austrian Ministry of Science and Research and 2015 she achieved third place of the Houska Award of the B&C Holding. Furthermore Regina Grillari has authored and co-authored more than 50 scientific publications and book chapters, 5 patents, and she is also co-founder and scientific advisor of TAmiRNA GmbH (founded 2012), co-founder of Phoenestra GmbH (2015) and also co-founder of Remute Bio GmbH (2016).



Otto Kanzler

Otto Kanzler, CEOOtto Kanzler, CEO and co-founder has more than 30 years experience in process- and business development in the biotech industry. Since 2007 he is serving as Management Consultant for production and technology-development for biotech- and pharma-industry, specified for strategic and economic issues. Between 1993 and 2007 he was department head at Boehringer Ingelheim Austria, responsible for the economic issues of the industrial biopharmaceutical business. Prior to this he was head of process development for biopharmaceutical processes at Boehringer Ingelheim Austria (1981-1993). Otto Kanzler is a serial entrepreneur having founded and co-founded several companies, all of which are still active - CEO / CFO of Remute Bio GmbH (founded 2016), co-founder and interim CEO / CFO of Phoenestra GmbH (founded 2015), Advisor of DirectSens GmbH (since 2015), co-founder and CEO of Syconium Lactic Acid GmbH (founded 2014), co-founder and CFO of TAmiRNA GmbH (founded 2012), co-founder and CEO of Evercyte GmbH und Chorus GmbH, (both founded 2011).